New research has identified 38 direct-to-consumer businesses marketing stem-cell treatments and exosome therapies for COVID-19 infections and, especially, long COVID, despite lacking approval by US Food and Drug Administration and other regulatory body in the United States. Descriptions of the businesses and an analysis of their marketing strategies are published in Stem Cell Reports.
COVID-19 activity in the United States last week showed more signs of declines, though deaths were up, and the World Health Organization's (WHO's) monthly snapshot of global activity suggests decreased activity, though the group cautioned that few countries are reporting data.
Why do some people have a more severe course of COVID-19 disease than others? A genome sequence database created by an international collaboration of researchers, including many from the University of Toronto and partner hospitals, may hold the answers to this question—and many more.
People with severe mental illness (SMI) are at a 50% increased risk of death from all causes following COVID-19 infections, according to a study yesterday in TheBritish Journal of Psychiatry.
Pfizer said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months after showing positive initial results. ..
Pfizer and other vaccine makers like Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against respiratory viruses that typically surge around the same time of the year.
